Improvement in margin pleases GSK’s Walmsley
This article was originally published in OTC Bulletin
Executive Summary
GlaxoSmithKline (GSK) is making “very good progress” on improving margins at its Consumer Healthcare business, according to chief executive officer Emma Walmsley.